MET and uveal melanoma: It has been reported that c-MET is expressed on uveal melanoma cells (Barisione et al., 2015) and the combination of c-MET inhibitors like crizotinib with PKC inhibitors may be useful in treating patients with uveal melanoma (Hitchman et al., 2021).